WARREN, N.J., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement ...
Please provide your email address to receive an email when new articles are posted on . The AQST-109 sublingual film provides needle-free delivery of epinephrine. AQST-109 achieved faster time to ...
Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech Company providing proprietary oral delivery platform via ...
PHOENIX,, Jan. 12, 2012 /PRNewswire/ -- Kedem Pharmaceuticals Inc. (OTCBB: KDMP), a specialty pharmaceutical company with focus on sublingual drug delivery system is pleased to announce that has ...
PHOENIX, AZ, Feb 07, 2012 (MARKETWIRE via COMTEX) -- Kedem Pharmaceuticals Inc. KDMP -4.17% , a specialty pharmaceutical company with focus on sublingual drug delivery is pleased to participate ...
(MENAFN- Newswire.com LLC) NAPLES, Fla., April 18, 2019 (Newswire.com) - Synergistic Therapeutics LLC has recently announced issuance of a U.S. Patent for a sublingual antidepressant lozenge with ...
The clinical trial data show that epinephrine delivered via orally administered Anaphylm™ (epinephrine) Sublingual Film is comparable to epinephrine delivered via autoinjector or manual intramuscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results